Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katie J Doores

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
The FEBS Journal|September 29, 2015
The HIV glycan shield as a target for broadly neutralizing antibodiesKatie J Doores
Annals of the New York Academy of Sciences|November 8, 2023
Humoral immunity to phlebovirus infectionKatie J Doores
Current Opinion in Virology|March 10, 2015
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine designMax Crispin, Katie J Doores
Chemical Communications (Cambridge, England)|February 23, 2005
"Polar patch" proteases as glycopeptiligasesKatie J Doores, Benjamin G Davis
Journal of Virology|August 6, 2010
Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16Katie J Doores, Dennis R Burton
Organic & Biomolecular Chemistry|July 18, 2008
Reagent switchable stereoselective beta(1,2) mannoside mannosylation: OH-2 of mannose is a privileged acceptorKatie J Doores, Benjamin G Davis
Current Topics in Microbiology and Immunology|July 27, 2018
Targeting Glycans on Human Pathogens for Vaccine DesignStefanie A Krumm, Katie J Doores
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 28, 2005
Exploring and exploiting the therapeutic potential of glycoconjugatesKatie J Doores, David P Gamblin, Benjamin G Davis
Journal of Molecular Biology|April 28, 2019
Protein and Glycan Mimicry in HIV Vaccine DesignGemma E Seabright, Katie J Doores, Dennis R Burton, et al.
Biochemical Society Transactions|May 23, 2018
Harnessing post-translational modifications for next-generation HIV immunogensJoel D Allen, Rogier W Sanders, Katie J Doores, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
The FEBS Journal|September 29, 2015
The HIV glycan shield as a target for broadly neutralizing antibodiesKatie J Doores
Annals of the New York Academy of Sciences|November 8, 2023
Humoral immunity to phlebovirus infectionKatie J Doores
Current Opinion in Virology|March 10, 2015
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine designMax Crispin, Katie J Doores
Chemical Communications (Cambridge, England)|February 23, 2005
"Polar patch" proteases as glycopeptiligasesKatie J Doores, Benjamin G Davis
Journal of Virology|August 6, 2010
Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16Katie J Doores, Dennis R Burton
Organic & Biomolecular Chemistry|July 18, 2008
Reagent switchable stereoselective beta(1,2) mannoside mannosylation: OH-2 of mannose is a privileged acceptorKatie J Doores, Benjamin G Davis
Current Topics in Microbiology and Immunology|July 27, 2018
Targeting Glycans on Human Pathogens for Vaccine DesignStefanie A Krumm, Katie J Doores
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 28, 2005
Exploring and exploiting the therapeutic potential of glycoconjugatesKatie J Doores, David P Gamblin, Benjamin G Davis
Journal of Molecular Biology|April 28, 2019
Protein and Glycan Mimicry in HIV Vaccine DesignGemma E Seabright, Katie J Doores, Dennis R Burton, et al.
Biochemical Society Transactions|May 23, 2018
Harnessing post-translational modifications for next-generation HIV immunogensJoel D Allen, Rogier W Sanders, Katie J Doores, et al.
Pageof 12